IP Library Granted Patent US 9,408,750
Granted Patent B2
US 9,408,750 · App. 13/462,817 · Granted Aug 9, 2016

Reduced-pressure treatment systems and methods employing debridement mechanisms

Inventors: Charles Alan Seegert (North Richland, TX); Robert Peyton Wilkes (San Antonio, TX)
Assignee: KCI Licensing, Inc.
A61F13/00068A61B17/32A61F13/00063A61M1/0084A61M1/0088A61M27/00A61B17/30A61B2017/00561Y10T29/49826
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,408,750
App. No.
13/462,817
Granted
Aug 9, 2016
Kind
B2
Abstract

Reduced-pressure treatment systems and methods are disclosed that employ debridement mechanisms to remove unwanted tissue. In one instance, a reduced-pressure treatment system for treating a tissue site on a patient includes a manifold member for distributing reduced pressure to the tissue site, a support member for disposing proximate the tissue site and the manifold, and a debridement mechanism coupled to the support member. The debridement mechanism is for debriding the tissue site. The system further includes a sealing drape for placing over the tissue site and manifold member. The sealing drape is operable to form a fluid seal over the tissue site and manifold member. The system also includes a reduced-pressure subsystem for delivering a reduced pressure to the sealing drape. The system may further include a chemical-debridement subsystem. Other systems, manifolds, and methods are disclosed.

Claims (26)

1. A reduced-pressure treatment system for treating a tissue site on a patient, the system comprising:

a manifold member adapted to distribute reduced pressure to the tissue site and contract in response to application of reduced pressure to the tissue site;

a support member mechanically coupled to the manifold member;

a debridement mechanism having a proximal end coupled to the support member and a distal end having at least one cutting edge extending from and operatively coupled to the support member to debride the tissue site, wherein the debridement mechanism is deformable to drive the at least one edge against the undesired tissue in response to contraction of the manifold member when induced by the application of reduced pressure;

a sealing drape for placing over the tissue site and manifold member and operable to form a fluid seal over the tissue site and manifold member;

a source of reduced-pressure for delivering a reduced pressure through the sealing drape to the manifold member.

2. The system of claim 1 , wherein the debridement mechanism comprises a pincer having a first blade and a second blade, each including one of the at least one cutting edges and being movable for debriding the tissue site in response to contraction of the manifold member.

3. The system of claim 2 , wherein the first blade and the second blade of the pincer move from an open position to a closed position when the manifold member contracts under the influence of reduced pressure.

4. The system of claim 1 , wherein the debridement mechanism comprises a debridement arm having a cutting edge movable for debriding the tissue site in response to contraction of the manifold member.

5. The system of claim 4 , wherein the debridement arm deforms to move from a first position to a second position when the manifold member by moving the cutting edge from a first position to a second position.

6. The system of claim 1 , further comprising a chemical-debridement subsystem for delivering a debriding chemical to the tissue site.

7. The system of claim 1 , further comprising a chemical-debridement subsystem for delivering a debriding chemical to the tissue site, wherein the chemical-debridement subsystem comprises a debriding chemical reservoir in fluid communication with the sealing drape whereby the debriding chemical is delivered to the tissue site.

8. The system of claim 1 , further comprising a chemical-debridement subsystem for delivering a debriding chemical to the tissue site, wherein the debriding chemical is one or more enzymes isolated from insect larvae.

9. The system of claim 1 , further comprising a chemical-debridement subsystem for delivering a debriding chemical to the tissue site, wherein the debriding chemical is one or more enzymes isolated from insect larvae, and wherein the larvae are larvae from Lucilia sericata.

10. The system of claim 1 , further comprising a chemical-debridement subsystem for delivering a debriding chemical to the tissue site, wherein the debriding chemical is one or more synthetic analogues of one or more enzymes isolated from insect larvae.

11. The system of claim 1 , further comprising a chemical-debridement subsystem for delivering a debriding chemical to the tissue site, wherein the debriding chemical is one or more synthetic analogues of one or more enzymes isolated from insect larvae, and wherein the larvae are larvae from Lucilia sericata.

12. The system of claim 1 , further comprising a chemical-debridement subsystem for delivering a debriding chemical to the tissue site, wherein the debriding chemical is a chemical selected from the group consisting of: collagenase, ficin, pepsin, trypsin, chymotrypsin, papain and elastase.

13. The system of claim 1 , wherein the debridement mechanism comprises a jaw formed by two of the at least one blade including a first jaw member and a second jaw member,

wherein the first jaw member and second jaw member are operable to move from a first, open position to a second, biting position under the influence of reduced pressure.

14. A manifold member for treating a tissue site on a patient, the manifold member comprising:

a manifold material adapted to distribute reduced pressure to the tissue site and contract in response to application of reduced pressure and distribute reduced pressure to the tissue site;

a support member mechanically coupled to the manifold material; and

a debridement mechanism having a proximal end coupled to the support member and a distal end having at least one cutting edge extending from and operatively coupled to the support member to debride the tissue site, wherein the debridement mechanism is deformable to drive the at least one cutting edge against the undesired tissue in response to contraction of the manifold material when induced by the application of reduced pressure.

15. The manifold member of claim 14 , wherein the debridement mechanism comprises a pincer having a first blade and a second blade, each including one of the at least one cutting edges and being movable for debriding the tissue site in response to contraction of the manifold member.

16. The manifold member of claim 15 , wherein the first blade and the second blade of the pincer move from an open position to a closed position under the influence of reduced pressure.

17. The manifold member of claim 15 , wherein the first blade and the second blade of the pincer move from an open position to a closed position under the influence of reduced pressure, and wherein the first blade and the second blade of the pincer move from a closed position to a collapsed position under the influence of additional reduced pressure.

Assignments (7)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 1, 2024
From: 3M INNOVATIVE PROPERTIES COMPANY
To: SOLVENTUM INTELLECTUAL PROPERTIES COMPANY
Reel/Frame 066432/0345 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 28, 2023
From: KCI LICENSING, INC.
To: 3M INNOVATIVE PROPERTIES COMPANY
Reel/Frame 064730/0218 →
RELEASE OF SECURITY INTEREST IN PATENTS Recorded Nov 7, 2019
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: KCI USA, INC.; KCI LICENSING, INC.
Reel/Frame 050966/0547 →
RELEASE OF SECURITY INTEREST REEL/FRAME 040098/0268 Recorded Feb 8, 2017
From: WILMINGTON TRUST
To: KCI USA, INC.
Reel/Frame 041666/0320 →
LIMITED THIRD LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Oct 7, 2016
From: KCI USA, INC.; LIFECELL CORPORATION; KCI LICENSING, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 040291/0237 →
SECOND LIEN SECURITY AGREEMENT Recorded Sep 21, 2016
From: KCI USA, INC.; LIFECELL CORPORATION; KCI LICENSING, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 040098/0268 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 31, 2012
From: SEEGERT, CHARLES ALAN; WILKES, ROBERT PEYTON
To: KCI LICENSING, INC.
Reel/Frame 028689/0348 →
Continuity (3)
Continuation 12639351 · Dec 16, 2009
Provisional Application 61140654 · Dec 24, 2008
Related Publication 20120220924A1 · Aug 30, 2012